Top

Current Atherosclerosis Reports

Published in:

16-02-2024 | Artificial Intelligence | Review

Implications of Bias in Artificial Intelligence: Considerations for Cardiovascular Imaging

Authors: Marly van Assen, Ashley Beecy, Gabrielle Gershon, Janice Newsome, Hari Trivedi, Judy Gichoya

Published in: Current Atherosclerosis Reports | Issue 4/2024

Abstract

Purpose of Review

Bias in artificial intelligence (AI) models can result in unintended consequences. In cardiovascular imaging, biased AI models used in clinical practice can negatively affect patient outcomes. Biased AI models result from decisions made when training and evaluating a model. This paper is a comprehensive guide for AI development teams to understand assumptions in datasets and chosen metrics for outcome/ground truth, and how this translates to real-world performance for cardiovascular disease (CVD).

Recent Findings

CVDs are the number one cause of mortality worldwide; however, the prevalence, burden, and outcomes of CVD vary across gender and race. Several biomarkers are also shown to vary among different populations and ethnic/racial groups. Inequalities in clinical trial inclusion, clinical presentation, diagnosis, and treatment are preserved in health data that is ultimately used to train AI algorithms, leading to potential biases in model performance. Despite the notion that AI models themselves are biased, AI can also help to mitigate bias (e.g., bias auditing tools).

Summary

In this review paper, we describe in detail implicit and explicit biases in the care of cardiovascular disease that may be present in existing datasets but are not obvious to model developers. We review disparities in CVD outcomes across different genders and race groups, differences in treatment of historically marginalized groups, and disparities in clinical trials for various cardiovascular diseases and outcomes. Thereafter, we summarize some CVD AI literature that shows bias in CVD AI as well as approaches that AI is being used to mitigate CVD bias.

Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al. Heart Disease and Stroke Statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143:e254–743. https://doi.org/10.1161/CIR.0000000000000950.CrossRefPubMed

Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74:2529–32. https://doi.org/10.1016/j.jacc.2019.10.009.CrossRefPubMed

Zhu S, Gilbert M, Chetty I, Siddiqui F. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: an analysis of the characteristics and intended use. Int J Med Inform. 2022;165:104828. https://doi.org/10.1016/j.ijmedinf.2022.104828.CrossRefPubMed

Hanneman K, Playford D, Dey D, van Assen M, Mastrodicasa D, Cook TS, et al. Value creation through artificial intelligence and cardiovascular imaging: a scientific statement from the American Heart Association. Circulation. 2024;149:e296–e311. https://doi.org/10.1161/CIR.0000000000001202.

Tat E, Bhatt DL, Rabbat MG. Addressing bias: artificial intelligence in cardiovascular medicine. Lancet Digit Health. 2020;2:e635–6. https://doi.org/10.1016/S2589-7500(20)30249-1.CrossRefPubMed

Zhang K, Khosravi B, Vahdati S, Faghani S, Nugen F, Rassoulinejad-Mousavi SM, Moassefi M, Jagtap JMM, Singh Y, Rouzrokh P, et al. Mitigating bias in radiology machine learning: 2. model development. Radiol Artif Intell. 2022;4:e220010. https://doi.org/10.1148/ryai.220010.CrossRefPubMedPubMedCentral

Rouzrokh P, Khosravi B, Faghani S, Moassefi M, Vera Garcia DV, Singh Y, Zhang K, Conte GM, Erickson BJ. Mitigating bias in radiology machine learning: 1. data handling. Radiol Artif Intell. 2022;4:e210290. https://doi.org/10.1148/ryai.210290.CrossRefPubMedPubMedCentral

Faghani S, Khosravi B, Zhang K, Moassefi M, Jagtap JM, Nugen F, Vahdati S, Kuanar SP, Rassoulinejad-Mousavi SM, Singh Y, et al. Mitigating bias in radiology machine learning: 3. performance metrics. Radiol Artif Intell. 2022;4:e220061. https://doi.org/10.1148/ryai.220061.CrossRefPubMedPubMedCentral

Chong LR, Tsai KT, Lee LL, Foo SG, Chang PC. Artificial intelligence predictive analytics in the management of outpatient MRI appointment no-shows. AJR Am J Roentgenol. 2020;215:1155–62. https://doi.org/10.2214/AJR.19.22594.CrossRefPubMed

10.

Winkel DJ, Suryanarayana VR, Ali AM, Gorich J, Buss SJ, Mendoza A, Schwemmer C, Sharma P, Schoepf UJ, Rapaka S. Deep learning for vessel-specific coronary artery calcium scoring: validation on a multi-centre dataset. Eur Heart J Cardiovasc Imaging. 2022;23:846–54. https://doi.org/10.1093/ehjci/jeab119.CrossRefPubMed

11.

Tzolos E, Williams MC, McElhinney P, Lin A, Grodecki K, Flores Tomasino G, Cadet S, Kwiecinski J, Doris M, Adamson PD, et al. Pericoronary adipose tissue attenuation, low-attenuation plaque burden, and 5-year risk of myocardial infarction. JACC Cardiovasc Imaging. 2022. https://doi.org/10.1016/j.jcmg.2022.02.004.CrossRefPubMedPubMedCentral

12.

Griffin WF, Choi AD, Riess JS, Marques H, Chang HJ, Choi JH, Doh JH, Her AY, Koo BK, Nam CW, et al. AI evaluation of stenosis on coronary CT angiography, comparison with quantitative coronary angiography and fractional flow reserve: a CREDENCE trial substudy. JACC Cardiovasc Imaging. 2022. https://doi.org/10.1016/j.jcmg.2021.10.020.CrossRefPubMed

13.

Bhuva AN, Bai W, Lau C, Davies RH, Ye Y, Bulluck H, McAlindon E, Culotta V, Swoboda PP, Captur G, et al. A multicenter, scan-rescan, human and machine learning CMR study to test generalizability and precision in imaging biomarker analysis. Circ Cardiovasc Imaging. 2019;12:e009214. https://doi.org/10.1161/CIRCIMAGING.119.009214.CrossRefPubMed

14.

Motwani M, Dey D, Berman DS, Germano G, Achenbach S, Al-Mallah MH, Andreini D, Budoff MJ, Cademartiri F, Callister TQ, et al. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J. 2017;38:500–7. https://doi.org/10.1093/eurheartj/ehw188.CrossRefPubMed

15.

van Rosendael AR, Maliakal G, Kolli KK, Beecy A, Al’Aref SJ, Dwivedi A, Singh G, Panday M, Kumar A, Ma X, et al. Maximization of the usage of coronary CTA derived plaque information using a machine learning based algorithm to improve risk stratification; insights from the CONFIRM registry. J Cardiovasc Comput Tomogr. 2018;12:204–9. https://doi.org/10.1016/j.jcct.2018.04.011.CrossRefPubMed

16.

Churchwell K, Elkind MSV, Benjamin RM, Carson AP, Chang EK, Lawrence W, Mills A, Odom TM, Rodriguez CJ, Rodriguez F, et al. Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association. Circulation. 2020;142:E454–68. https://doi.org/10.1161/Cir.0000000000000936.CrossRefPubMed

17.

Javed Z, Haisum Maqsood M, Yahya T, Amin Z, Acquah I, Valero-Elizondo J, Andrieni J, Dubey P, Jackson RK, Daffin MA, et al. Race, racism, and cardiovascular health: applying a social determinants of health framework to racial/ethnic disparities in cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2022;15: e007917. https://doi.org/10.1161/CIRCOUTCOMES.121.007917.CrossRefPubMed

18.

Kyalwazi AN, Loccoh EC, Brewer LC, Ofili EO, Xu JM, Song Y, Maddoxe KEJ, Yeh RW, Wadhera RK. Disparities in cardiovascular mortality between Black and White adults in the United States, 1999 to 2019. Circulation. 2022;146:211–28. https://doi.org/10.1161/Circulationaha.122.060199.CrossRefPubMedPubMedCentral

19.

Centers for Disease Control and Prevention. CDC health disparities and inequalities report — United States, 2013. MMWR. 2013;62(Suppl 3):157–60.

20.

Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in cardiovascular mortality related to heart failure in the United States. J Am Coll Cardiol. 2019;73(18):2354–5. https://doi.org/10.1016/j.jacc.2019.02.042.

21.

Mazimba S, Peterson PN. JAHA spotlight on racial and ethnic disparities in cardiovascular disease. J Am Heart Assoc. 2021;10(17):e023650. https://doi.org/10.1161/JAHA.121.023650.

22.

Hannan EL, Racz MJ, Walford G, Jacobs AK, Stamato NJ, Gesten F, Berger PB, Sharma S, King SB. Disparities in the use of drug-eluting coronary stents by race, ethnicity, payer, and hospital. Can J Cardiol. 2016;32: 987.e25 https://doi.org/10.1016/j.cjca.2016.01.012

23.

Fang J, Yang QH, Ayala C, Loustalot F. Disparities in access to care among US adults with self-reported hypertension. Am J Hypertens. 2014;27:1377–86. https://doi.org/10.1093/ajh/hpu061.CrossRefPubMedPubMedCentral

24.

Sullivan S, Hammadah M, Wilmot K, Ramadan R, Pearce BD, Shah A, Kaseer B, Gafeer MM, Lima BB, Kim JH, et al. Young women with coronary artery disease exhibit higher concentrations of interleukin-6 at baseline and in response to mental stress. J Am Heart Assoc. 2018;7:e010329. https://doi.org/10.1161/JAHA.118.010329.CrossRefPubMedPubMedCentral

25.

Kershaw KN, Lewis TT, Diez Roux AV, Jenny NS, Liu K, Penedo FJ, et al. Self-reported experiences of discrimination and inflammation among men and women: the multi-ethnic study of atherosclerosis. Health Psychol. 2016;35(4):343–50. https://doi.org/10.1037/hea0000331.

26.

Liaudat CC, Vaucher P, De Francesco T, Jaunin-Stalder N, Herzig L, Verdon F, Favrat B, Locatelli I, Clair C. Sex/gender bias in the management of chest pain in ambulatory care. Womens Health. 2018;14:1745506518805641 https://doi.org/10.1177/1745506518805641 (Artn)

27.

Shahian DM, Jacobs JP, Badhwar V, Kurlansky PA, Furnary AP, Cleveland JC, Lobdell KW, Vassileva C, von Ballmoos MCW, Thourani VH, et al. The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 1-background, design considerations, and model development. Ann Thorac Surg. 2018;105:1411–8. https://doi.org/10.1016/j.athoracsur.2018.03.002.CrossRefPubMed

28.

Sambola A, Del Blanco BG, Kunadian V, Vogel B, Chieffo A, Vidal M, Ratcovich H, Botti G, Wilkinson C, Mehran R. Sex-based differences in percutaneous coronary intervention outcomes in patients with ischaemic heart disease. Eur Cardiol. 2023;18:e06. https://doi.org/10.15420/ecr.2022.24.CrossRefPubMedPubMedCentral

29.

Daugherty SL, Magid DJ. Do sex differences exist in patient preferences for cardiovascular testing? Ann Emerg Med. 2011;57:561–2. https://doi.org/10.1016/j.annemergmed.2011.01.010.CrossRefPubMedPubMedCentral

30.

Lee P, Le Saux M, Siegel R, Goyal M, Chen C, Ma Y, Meltzer AC. Racial and ethnic disparities in the management of acute pain in US emergency departments: meta-analysis and systematic review. Am J Emerg Med. 2019;37:1770–7. https://doi.org/10.1016/j.ajem.2019.06.014.CrossRefPubMed

31.

Hsia RY, Sarkar N, Shen YC. Impact of ambulance diversion: Black patients with acute myocardial infarction had higher mortality than Whites. Health Aff (Millwood). 2017;36:1070–7. https://doi.org/10.1377/hlthaff.2016.0925.CrossRefPubMed

32.

Graham G. Racial and ethnic differences in acute coronary syndrome and myocardial infarction within the United States: from demographics to outcomes. Clin Cardiol. 2016;39:299–306. https://doi.org/10.1002/clc.22524.CrossRefPubMedPubMedCentral

33.

National Healthcare Quality and Disparities Report. Content last reviewed July 2023. Rockville: Agency for Healthcare Research and Quality; 2019. https://www.ahrq.gov/research/findings/nhqrdr/nhqdr19/index.html.

34.

Popescu I, Huckfeldt P, Pane JD, Escarce JJ. Contributions of geography and nongeographic factors to the White-Black gap in hospital quality for coronary heart disease: a decomposition analysis. J Am Heart Assoc. 2019;8: e011964 https://doi.org/10.1161/JAHA.119.011964 (ARTN)

35.

Johnson A. Understanding why Black patients have worse coronary heart disease outcomes: does the answer lie in knowing where patients seek care? J Am Heart Assoc. 2019;8:e014706. https://doi.org/10.1161/jaha.119.014706.CrossRefPubMedPubMedCentral

36.

Norris CM, Yip CYY, Nerenberg KA, Clavel MA, Pacheco C, Foulds HJA, Hardy M, Gonsalves CA, Jaffer S, Parry M, et al. State of the science in women’s cardiovascular disease: a Canadian perspective on the influence of sex and gender. J Am Heart Assoc. 2020;9:e015634. https://doi.org/10.1161/JAHA.119.015634.CrossRefPubMedPubMedCentral

37.

Geller SE, Koch AR, Roesch P, Filut A, Hallgren E, Carnes M. The more things change, the more they stay the same: a study to evaluate compliance with inclusion and assessment of women and minorities in randomized controlled trials. Acad Med. 2018;93:630–5. https://doi.org/10.1097/Acm.0000000000002027.CrossRefPubMedPubMedCentral

38.

Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women’s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141(7):540–8. https://doi.org/10.1161/Circulationaha.119.043594.

39.

Lolic M, Araojo R, Okeke M, Temple RUS. racial and ethnic participation in global clinical trials by therapeutic areas. J Clin Pharm Ther. 2021;46:1576–81. https://doi.org/10.1111/jcpt.13532.CrossRefPubMedPubMedCentral

40.

Lewsey SC, Breathett K. Racial and ethnic disparities in heart failure: current state and future directions. Curr Opin Cardiol. 2021;36(3):320–8. https://doi.org/10.1097/Hco.0000000000000855.CrossRefPubMedPubMedCentral

41.

Ford C, Xie CX, Low A, Rajakariar K, Koshy AN, Sajeev JK, et al. Comparison of 2 smart watch algorithms for detection of atrial fibrillation and the benefit of clinician interpretation: SMART WARS Study. JACC Clin Electrophysiol. 2022;8(6):782–91. https://doi.org/10.1016/j.jacep.2022.02.013.

42.

Bent B, Goldstein BA, Kibbe WA, Dunn JP. Investigating sources of inaccuracy in wearable optical heart rate sensors. NPJ Digit Med. 2020;3:18. https://doi.org/10.1038/s41746-020-0226-6.

43.

Colvonen PJ. Response to: investigating sources of inaccuracy in wearable optical heart rate sensors. Npj Digit Med. 2021;4:38 https://doi.org/10.1038/s41746-021-00408-5 (ARTN)

44.

Breathett K, Yee E, Pool N, Hebdon M, Crist JD, Yee RH, Knapp SM, Solola S, Luy L, Herrera-Theut K, et al. Association of gender and race with allocation of advanced heart failure therapies.

45.

• Gichoya JW, Banerjee I, Bhimireddy AR, Burns JL, Celi LA, Chen LC, Correa R, Dullerud N, Ghassemi M, Huang SC, et al. AI recognition of patient race in medical imaging: a modelling study. Lancet Digit Health. 2022;4:e406–14. https://doi.org/10.1016/S2589-7500(22)00063-2. (This study shows that race can be detected from unknown signals in medical images, potentially biasing AI evaluations).CrossRefPubMedPubMedCentral

46.

McClelland RL, Chung HJ, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age - results from the multi-ethnic study of atherosclerosis (MESA). Circulation. 2006;113:30–7. https://doi.org/10.1161/Circulationaha.105.580696.CrossRefPubMed

47.

Burrell S, MacDonald A. Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol. 2006;34:193–211(quiz 212–194)

48.

Taqueti VR, Dorbala S, Wolinsky D, Abbott B, Heller GV, Bateman TM, Mieres JH, Phillips LM, Wenger NK, Shaw LJ. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.

49.

Aggarwal NR, Bond RM, Mieres JH. The role of imaging in women with ischemic heart disease.

50.

Betancur J, Otaki Y, Motwani M, Fish MB, Lemley M, Dey D, Gransar H, Tamarappoo B, Germano G, Sharir T, et al. Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning. JACC Cardiovasc Imaging. 2018;11:1000–9. https://doi.org/10.1016/j.jcmg.2017.07.024.CrossRefPubMed

51.

•• Puyol-Anton E, Ruijsink B, Mariscal Harana J, Piechnik SK, Neubauer S, Petersen SE, Razavi R, Chowienczyk P, King AP. Fairness in cardiac magnetic resonance imaging: assessing sex and racial bias in deep learning-based segmentation. Front Cardiovasc Med. 2022;9:859310. https://doi.org/10.3389/fcvm.2022.859310. (This study shows that AI applications, based on the training data, can have decreased performance in underrepresented populations).CrossRefPubMedPubMedCentral

52.

Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366:447–53. https://doi.org/10.1126/science.aax2342.

53.

Stray J. The AI learns to lie to please you: preventing biased feedback loops in machine-assisted intelligence analysis. Analytics. 2023;2:350–8.CrossRef

54.

Lenert MC, Matheny ME, Walsh CG. Prognostic models will be victims of their own success, unless. J Am Med Inform Assn. 2019;26:1645–50. https://doi.org/10.1093/jamia/ocz145.CrossRef

55.

Drukker K, Chen W, Gichoya J, Gruszauskas N, Kalpathy-Cramer J, Koyejo S, Myers K, Sa RC, Sahiner B, Whitney H, et al. Toward fairness in artificial intelligence for medical image analysis: identification and mitigation of potential biases in the roadmap from data collection to model deployment. J Med Imaging (Bellingham). 2023;10:061104. https://doi.org/10.1117/1.JMI.10.6.061104.CrossRefPubMed

56.

• Miller RJH, Singh A, Otaki Y, Tamarappoo BK, Kavanagh P, Parekh T, Hu LH, Gransar H, Sharir T, Einstein AJ, et al. Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT images. Eur J Nucl Med Mol Imaging. 2023;50:387–97. https://doi.org/10.1007/s00259-022-05972-w. (This study demonstrated that AI can also be used to mitigate bias in imaging studies).CrossRefPubMed

57.

Chen Y, Clayton EW, Novak LL, Anders S, Malin B. Human-centered design to address biases in artificial intelligence. J Med Internet Res. 2023;25:e43251. https://doi.org/10.2196/43251. (ARTN)

58.

Vyas DA, Eisenstein LG, Jones DS. Hidden in plain sight - reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383:874–82. https://doi.org/10.1056/NEJMms2004740.

59.

Suri JS, Bhagawati M, Paul S, Protogeron A, Sfikakis PP, Kitas GD, Khanna NN, Ruzsa Z, Sharma AM, Saxena S, et al. Understanding the bias in machine learning systems for cardiovascular disease risk assessment: the first of its kind review. Comput Biol Med. 2022;142:105204. https://doi.org/10.1016/j.compbiomed.2021.105204.CrossRefPubMed

60.

Calaprice-Whitty D, Galil K, Salloum W, Zariv A, Jimenez B. Improving clinical trial participant prescreening with artificial intelligence (AI): a comparison of the results of ai-assisted vs standard methods in 3 oncology trials. Ther Innov Regul Sci. 2020;54:69–74. https://doi.org/10.1007/s43441-019-00030-4.CrossRefPubMed

61.

Administration USFaD. Proposed regulatory framework for modifications to artificial intelligence / machine learning (AI/ML)-based software as a medical device (SaMD) In: https://www.fda.gov/downloads/MedicalDevices/DigitalHealth/SoftwareasaMedicalDevice/UCM635052.pdf.; 2019.

62.

Geis JR, Brady AP, Wu CC, Spencer J, Ranschaert E, Jaremko JL, Langer SG, Borondy Kitts A, Birch J, Shields WF, et al. Ethics of artificial intelligence in radiology: summary of the joint European and North American multisociety statement. Radiology. 2019;293:436–40. https://doi.org/10.1148/radiol.2019191586.CrossRefPubMed

63.

Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381:1909–17. https://doi.org/10.1056/NEJMoa1901183.CrossRefPubMedPubMedCentral

Title: Implications of Bias in Artificial Intelligence: Considerations for Cardiovascular Imaging
Authors: Marly van Assen
Ashley Beecy
Gabrielle Gershon
Janice Newsome
Hari Trivedi
Judy Gichoya
Publication date: 16-02-2024
Publisher: Springer US
Keyword: Artificial Intelligence
Published in: Current Atherosclerosis Reports / Issue 4/2024
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-024-01190-x

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com